MedTrace Logo

Vitamin D Deficiency and Effect of Its Supplementation on Interstitial Lung Diseases(ILD).

NCT04100226 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2019-09-24

No results posted yet for this study

Summary

This study evaluates serum level of Vitamin D in Interstitial Lung Diseases in patients with Interstitial Lung Diseases other than connective tissue diseases associated-Interstitial Lung Diseases and effects of its supplementation.

All patients will receive the standard regimen of treatment (corticosteroids and immunosuppressive drugs)and will be randomly assigned to either Group 1:who will receive Vitamin D supplementation (Interventional group)or Group 2:who will not receive Vitamin D supplementation(Control group).

Conditions

  • Lung Diseases, Interstitial
  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 (1.25 (OH)2 cholecalciferol)

Vitamin D 3 in a dose of 200.000 IU intramuscular injection every 2 weeks for 3 months for Vitamin D deficient interstitial lung disease patients and every month for 3 months for vitamin D insufficient interstitial lung disease patients. calcium supplementation in form of ca carbonate 600 mg oral capsule once daily for 3 months for all patients.

Sponsors & Collaborators

  • Samah Selim Abdel Naiem Selim

    collaborator UNKNOWN

  • Naglaa Bakry Ahmed Elkhatib

    collaborator UNKNOWN

  • Cairo University

    lead OTHER

Principal Investigators

  • Esmat Ai Ali, MD · Professor of chest diseases,Faculty of Medicine, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2019-11-01
Completion
2020-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04100226 on ClinicalTrials.gov